CTD-M 50mg/12.5mg Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Metoprolol Succinate (50mg) + Chlorthalidone (12.5mg)
Overview CTD-M 50mg/12.5mg Tablet
The combination tablet CTD-M (50mg/12.5mg) is indicated for managing hypertension (high blood pressure) when monotherapy proves insufficient. It contributes to blood pressure regulation and diminishes the risk of future strokes and heart attacks. Early administration improves survival rates following a cardiac event. This medication, ideally taken once daily in the morning (with or without food), should be continued as prescribed, even in the absence of noticeable symptoms, since hypertension is often asymptomatic. Discontinuation can worsen the condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, enhance blood pressure control. Close adherence to your physician's instructions is vital. Common side effects include nausea, constipation, diarrhea, and fatigue; consult your doctor if these persist, worsen, or are bothersome. Adequate hydration is recommended to mitigate potential side effects like muscle weakness, dry mouth, and thirst. Initial dizziness or headache, possibly due to blood pressure reduction, usually subsides. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, pregnancy, or breastfeeding. Inform your doctor of all other medications, particularly those for hypertension or heart problems. Regular monitoring of blood pressure, kidney function, blood glucose, and electrolyte levels (potassium, magnesium) is necessary to ensure therapeutic efficacy.
Uses of CTD-M 50mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of CTD-M 50mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The CTD-M 50mg/12.5mg tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of CTD-M 50mg/12.5mg Tablet:
- Nausea
- Constipation
- Diarrhea
- Fatigue
- Headache
- Dizziness
- Slow heart rate
- Increased blood uric acid
- Decreased potassium level in blood
- Glucose intolerance
- Altered blood lipid level
- Cold extremities
- Decreased magnesium level in blood
- Increased calcium level in blood
How to use CTD-M 50mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg/12.5mg CTD-M tablet whole; do not chew, crush, or divide it. This medication can be administered with or without food, though consistent timing is recommended.
How CTD-M 50mg/12.5mg Tablet works:
Each CTD-M 50mg/12.5mg tablet merges Metoprolol Succinate and Chlorthalidone, two agents that decrease blood pressure. Metoprolol Succinate, a beta-blocker, acts directly on the heart, slowing its rate and enhancing its pumping efficiency. Chlorthalidone, a diuretic, reduces blood pressure by eliminating excess fluid and electrolytes, while concurrently promoting vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with CTD-M 50mg/12.5mg tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of CTD-M 50mg/12.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of CTD-M 50mg/12.5mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking a CTD-M 50mg/12.5mg tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using CTD-M 50mg/12.5mg tablets, as dose modification may be necessary. Consultation with a physician is advised, and the use of CTD-M 50mg/12.5mg tablets is generally discouraged in such cases.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using CTD-M 50mg/12.5mg tablets, potentially requiring dosage modification. A physician's consultation is advised. CTD-M 50mg/12.5mg tablets are contraindicated in individuals with severe liver dysfunction.
What if you forget to take CTD-M 50mg/12.5mg Tablet :
Should you forget to take your CTD-M 50mg/12.5mg Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About CTD-M 50mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |




